Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
- To evaluate the safety and tolerability of GS-9620 in adult subjects with chronic hepatitis B (CHB) infection who are currently not being treated -To evaluate the efficacy of GS-9620 as measured by the change from Baseline (BL) to Week 24 in serum Hepatitis B surface Antigen (HBsAg log10 IU/mL) levels
Inclusion criteria
- Treatment of Subjects with Chronic Hepatitis B and who are currently not on Treatment